Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 2.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000A84 | D. W. Miles [Royaume-Uni] ; S. L. De Haas [Suisse] ; L. Y. Dirix [Belgique] ; G. Romieu [France] ; A. Chan [Australie] ; X. Pivot [France] ; P. Tomczak [Pologne] ; L. Provencher [Canada] ; J. Cortes [Espagne] ; P. R. Delmar [Suisse] ; S. J. Scherer [États-Unis] | Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer |
| 006368 | M. Gershanovich [Russie] ; H. A. Chaudri [Suisse] ; D. Campos [Argentine] ; H. Lurie [Israël] ; A. Bonaventura [Australie] ; M. Jeffrey [Nouvelle-Zélande] ; F. Buzzi [Italie] ; I. Bodrogi [Hongrie] ; H. Ludwig [Autriche] ; P. Reichardt [Allemagne] ; N. O'Higgins [Irlande (pays)] ; G. Romieu [France] ; P. Friederich [Suisse] ; M. Lassus [Suisse] | Letrozole, a new oral aromatase inhibitor : Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer |
| This area was generated with Dilib version V0.6.33. |  |